Bhupendra Prajapati - Böcker

HUMAN-MACHINE INTERFACE The book contains the latest advances in healthcare and presents them in the frame of the Human-Machine Interface (HMI). The Human-Machine Interface (HMI) industry has witnessed the evolution from a simple push button to a modern touch-screen display. HMI is a user interface that allows humans to operate controllers for machines, systems, or instruments. Most medical procedures are improved by HMI systems, from calling an ambulance to ensuring that a patient receives adequate treatment on time. This book describes the scenario of biomedical technologies in the context of the advanced HMI, with a focus on direct brain-computer connection. The book describes several HMI tools and related techniques for analyzing, creating, controlling, and upgrading healthcare delivery systems, and provides details regarding how advancements in technology, particularly HMI, ensure ethical and fair use in patient care. Audience The target audience for this book is medical personnel and policymakers in healthcare and pharmaceutical professionals, as well as engineers and researchers in computer science and artificial intelligence.

The book gives comprehensive insights into the cutting-edge intersection of computational methods and neuropharmacology, making it an essential resource for understanding and advancing medication for neurological and psychiatric disorders. Computational Neuropharmacology is an in-depth exploration of the convergence of computational methods with neuropharmacology, a science concerned with understanding pharmacological effects on the nervous system. This volume explores the most recent breakthroughs and potential advances in computational neuropharmacology, providing an extensive overview of the computational tools that are transforming medication discovery and development for neurological and psychiatric illnesses. Fundamental principles of computational neuropharmacology, descriptions of molecular-level interactions and their consequences for modern neuropharmacology, and an introduction to theoretical neuroscience are highlighted throughout this resource. Additionally, this study addresses computational attitudes in counseling psychology to improve therapeutic procedures through data-driven insights. Computational psychiatry uses computational technologies to bridge the gap between the molecular basis and clinical symptoms of psychiatric diseases. This volume covers computational approaches to drug discovery in neurohumoral transmission and signal transduction, Parkinson’s disease, epilepsy, and Alzheimer’s disease, and the use of molecular docking and machine learning in drug development for neurological disorders. It also discusses the use of computational methods to uncover potential treatments for autism spectrum disorder, depression, and anxiety. Audience This book is a valuable resource for computer scientists, engineers, researchers, clinicians, and students, providing a detailed understanding of the computational tools that are changing the developing field of neuropharmacology, leading the future of medication discovery and development for neurological and psychiatric illnesses by combining modern computational approaches with neuropharmacological research.

Extensive attempts for developing cancer vaccines over the last 50 years have been made, but with minimal success. The current research in genetics, molecular biology, biochemistry, and immunology has revived interest in these immunotherapies and enabled the development of potential cancer vaccine candidates. This book, Cancer Vaccination and Challenges, in two volumes, deals with the very relevant issue of cancer vaccines and the various challenges their development and delivery present.Volume 1: Different Strategies for Therapeutic Cancer Vaccine Development deals with different strategies of cancer vaccine development. The primary focus of this volume is the techniques for the development of therapeutic cancer vaccines. It helps clarify the current need for vaccines in cancer treatment, exploring deeper information such as the roles of tumor antigens, proteins/peptides, microbial genes, and stem cells for the development of vaccines for cancer management. The volume also provides latest insights on DNA- and RNA-based cancer vaccines, eventually covering the regulatory perspectives for the cancer vaccine developments.Volume 2: Delivery Strategies for Cancer Vaccine and Immunotherapy in Management of Various Carcinomas presents an understanding of delivery strategies of cancer vaccines for the management of various forms of carcinoma. It discusses the management of various carcinomas using vaccines, examining the prospects of delivering immuno-oncology therapies, focusing specifically on the affective drug delivery strategies for treatment of lung, prostate, and pancreatic carcinomas. The volume provides an overview of the current vaccine systems, adjuvants, and delivery methods that are being explored or have been approved. It also focuses on therapeutic cancer vaccines that could be used to prevent the spread of advanced malignancies that are resistant to standard treatments, including surgery, radiation therapy, and chemotherapy.This two-volume book will be a valuable resource for researchers with a pharmaceutical background and professionals working in the field of biomedical science, engineering, vaccine development, and cancer therapy.

Volume 1: Strategies for Therapeutic Cancer Vaccine Development deals with different strategies of cancer vaccine development, focusing on techniques for the development of therapeutic cancer vaccines and the roles of tumor antigens, proteins/peptides, microbial genes, and stem cells for the development of vaccines for cancer management. Volume 2: Delivery Strategies for Cancer Vaccine and Immunotherapy in Management of Various Carcinomas covers delivery strategies of cancer vaccines for the management of various forms of carcinoma, examining the prospects of delivering immuno-oncology therapies, focusing specifically on the effective drug delivery strategies for treatment of lung, prostate, and pancreatic carcinomas.

Volume 1: Strategies for Therapeutic Cancer Vaccine Development deals with strategies of cancer vaccine development, focussing on the techniques for the development of therapeutic cancer vaccines and the role of tumor antigens, proteins/peptides, microbial genes, and stem cells for the development of vaccines for cancer management. .Volume 2: Delivery Strategies for Cancer Vaccine and Immunotherapy in Management of Various Carcinomas covers delivery strategies of cancer vaccines for the management of various forms of carcinoma, examining the prospects of delivering immuno-oncology therapies, focusing specifically on effective drug delivery strategies for the treatment of lung, prostate, and pancreatic carcinomas.

Excipients are important components of drug formulations, playing a critical role in ensuring the safety, efficacy, and stability of pharmaceutical products. In recent years, there has been a growing demand for advanced drug delivery systems that can improve the bioavailability, targeting, and sustained release of therapeutics. The development of these systems relies heavily not only on excipients but also on the use of processed excipients, which have been specifically designed and engineered to meet the unique challenges and requirements of advanced drug delivery.This new volume provides a comprehensive overview of the state-of-art research on processed excipients and their utilization in fabrication of advanced drug delivery. Beginning with an introduction and overview, the volume covers novel solid dosage forms, pharmaceutical and biomedical applications, nasal drug delivery, ocular drug delivery, transdermal drug delivery, parenteral medication delivery, pharmacokinetics and pharmacodynamics of processed excipients, and much more.